About XCyton Diagnostics
XCyton Diagnostics is a Healthcare company based in Bengaluru (India) founded in 1993 by Latha Lakshman. Provider of molecular diagnostic products and services. The company has 23 employees. XCyton Diagnostics was last valued at $4.88 million in March 2014. Its Indian entity Xcyton Diagnostics Private Limited reported revenue of ₹1.59 Cr. XCyton Diagnostics offers products and services including Syndrome Evaluation System and Molecular Diagnostic Services. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified.
Company details
XCyton Diagnostics was founded in 1993 in Bengaluru, India, within the healthcare sector. Molecular diagnostic products and services are offered, with a focus on medical diagnosis for critical care infections. Immunodiagnostic services, molecular diagnostics, and clinical tests are included in the portfolio. Operations are based in India, serving diagnostic needs in clinical settings.
- Headquarters Bengaluru, India
- Employees 23
- Founders Latha Lakshman
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website xcyton.com
- Social LinkedIn X
- Legal Name Xcyton Diagnostics Private Limited
- Date of Incorporation 30 Sep, 1993
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.59 Cr
FY 2025 · -85% YoY
- Net Loss-₹2.49 Cr
FY 2025 · -157% margin
- EBITDA-₹2.36 Cr
FY 2025 · -148% margin
- Latest Funding Round$167.05K (USD), Unspecified
Mar 2014
- InvestorsFidelity Investments
& 5 more
- Employee Count23
Associated legal entities of XCyton Diagnostics
XCyton Diagnostics operates through Xcyton Diagnostics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Xcyton Diagnostics Private Limited CIN U33112KA1993PTC014776 | Active | 30 Sep 1993 | Bangalore, Karnataka | ₹1.6 Cr | 23 | 2 | View details |
Products & Services of XCyton Diagnostics
XCyton Diagnostics offers a comprehensive portfolio of products and services, including Syndrome Evaluation System and Molecular Diagnostic Services.
Patented technology for rapid multiplex amplification and syndrome identification.
Offers tests and facilities for critical care diagnostics applications.
Funding Insights of XCyton Diagnostics
- Total Rounds 5
- Last Round Unspecified — $167,048
- First Round $212,679
(Mar 2007)
- Investors Count 6
All 5 funding rounds of XCyton Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2014 | $167,048 | Unspecified | $4.88M | Fidelity Investments | |
| Nov 2011 | $4.5M | Unspecified | – | Fidelity Investments | |
| Dec 2007 | $381,180 | Unspecified | $8.4M | – | |
| Mar 2007 | $231,260 | Unspecified | $••••• | Amvar Ventures | – |
| Mar 2007 | $212,679 | Unspecified | $••••• | Arun Kumar Sekhran |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2014 | $4.88M | •••••••• |
| Dec 2007 | $8.4M | •••••••• |
| Mar 2007 | $••••• | •••••••• |
| Mar 2007 | $••••• | •••••••• |
Full valuation and stage history of XCyton Diagnostics
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $4.88M (Mar 2014). 6 investors in total: 3 institutional and 3 angel.
Investors in XCyton Diagnostics
XCyton Diagnostics has secured backing from 6 investors, including institutional and angel investors. Prominent investors backing the company include Fidelity Investments, Fil Capital Advisors Trustee Company and Amvar Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | 1946 | fidelity.com | Boston, United States | |
Trustee services in financial advising are managed in India. | Gurugram, India | |||
AK Arun Kumar Sekhran | unknown_031817fcc3ad42a39 | |||
SR Sudha Ranganathan | unknown_fe9c29c4777d4f41a | |||
AN A N S Kumar | unknown_86af4906625f4858a |
Investor details for XCyton Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Xcyton Diagnostics Private Limited (XCyton Diagnostics)
Xcyton Diagnostics Private Limited is the primary company behind XCyton Diagnostics. The board of Xcyton Diagnostics Private Limited currently have 2 directors; the longest-serving is Venkata Ravikumar Banda, appointed in 1993. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkata Ravikumar Banda DIN 00109648 | Director | 30 Sep 1993 | 33 yrs 1 mo | Xcyton Diagnostics Private Limited |
| Latha Padinjyaravedu DIN 00109903 | Director | 15 Jul 2001 | 25 yrs 3 mo | Xcyton Diagnostics Private Limited |
People of XCyton Diagnostics
1 people are tracked at XCyton Diagnostics (1 in leadership); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Latha Lakshman | Co-Founder | Leadership |
Complete people profiles for XCyton Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of XCyton Diagnostics
Figures of Xcyton Diagnostics Private Limited, the primary company behind XCyton Diagnostics, for FY 2025. Revenue was ₹1.59 Cr (-85% year on year). Net loss was -₹2.49 Cr (-157% margin). EBITDA was -₹2.36 Cr (-148% margin). Revenue has grown at a compounded annual rate of -37% over three years and -18% over five years.
- ₹1.59 CrRevenue · FY 2025 · -85% YoY
- -₹2.49 CrNet loss · -157% margin
- -₹2.36 CrEBITDA · -148% margin
- ₹1.98 CrPaid-up capital
- 23Employees (provident fund records)
- -37%Revenue CAGR, 3 years
- -18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Xcyton Diagnostics Private Limited are on its company page.
Detailed financial statements for XCyton Diagnostics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of XCyton Diagnostics
4 dated milestones of XCyton Diagnostics across 21 years, from founding to its latest funding, stage changes and deals.
- Founded XCyton Diagnostics is founded.
- Funding First funding round of $213K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Unspecified, of $167K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Xcyton Diagnostics
Complete news archive for XCyton Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about XCyton Diagnostics
XCyton Diagnostics was founded in 1993 and raised its 1st funding round 14 years after it was founded.
XCyton Diagnostics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
XCyton Diagnostics has 23 employees.
The primary company behind XCyton Diagnostics, Xcyton Diagnostics Private Limited, reported revenue of ₹1.59 Cr for FY 2025, down 85% year on year.
XCyton Diagnostics was founded in 1993 in Bengaluru, India, within the healthcare sector. Molecular diagnostic products and services are offered, with a focus on medical diagnosis for critical care infections. Immunodiagnostic services, molecular diagnostics, and clinical tests are included in the portfolio. Operations are based in India, serving diagnostic needs in clinical settings.
XCyton Diagnostics offers Syndrome Evaluation System and Molecular Diagnostic Services.
XCyton Diagnostics has 6 investors. Key investors include Fidelity Investments, Fil Capital Advisors Trustee Company, Amvar Ventures, Arun Kumar Sekhran, and Sudha Ranganathan.
The valuation of XCyton Diagnostics is $4.88M as of Mar 2014.
XCyton Diagnostics operates through Xcyton Diagnostics Private Limited.
The legal entities of XCyton Diagnostics currently have 2 directors, including Latha Padinjyaravedu, Venkata Ravikumar Banda.